Humana Inc. HUM
417.97 USD +7.56 (+1.84%)
At closeNov 3, 2026, 4:00 PM EST
417.87 -0.10 -0.02%
After hours · Nov 3, 4:00 PM ET
407.36 Day range 422.65
163.11 52-week range 456.50
- YTD
- +63.19%
- 1 year
- +49.32%
Analyst view
Consensus: buy
Buy
Price target (mean) 465.13 +11.3% upside
Now 417.97
- Target (low)
- 280.00
- Target (mean)
- 465.13
- Target (high)
- 596.00
Ratings (0m) 26 16 buy · 9 hold · 1 sell
- Strong buy3
- Buy13
- Hold9
- Sell1
- Strong sell0
Recommendation trend
- This month 26
- 1 month ago 26
- 2 months ago 26
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.00 | -1.16 – -0.60 | 3.24 | -131.0% | 40.89B | +25.2% | 23 |
| Next quarter | -7.86 | -10.65 – -6.61 | -3.96 | -98.6% | 41.26B | +26.9% | 23 |
| Current year | 9.16 | 8.45 – 10.55 | 17.14 | -46.6% | 162.80B | +25.6% | 26 |
| Next year | 17.09 | 10.39 – 20.75 | 9.16 | +86.6% | 168.69B | +3.6% | 26 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 12, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 12, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 12, 2026 | Raymond James | Upgrade | Market Perform | Outperform |
| Oct 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 9, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 9, 2026 | Baird | Upgrade | Neutral | Outperform |
| Oct 7, 2026 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Sep 25, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Aug 10, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Jul 31, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jul 31, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Jul 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 30, 2026 | Raymond James | Downgrade | Outperform | Market Perform |
| Jul 14, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jul 14, 2026 | Truist Securities | Maintained | Hold | Hold |
| Jul 13, 2026 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Jul 9, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jun 24, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jun 11, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jun 4, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jun 4, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jun 1, 2026 | Truist Securities | Maintained | Hold | Hold |
